RecruitingNCT05880199

BSGM to Evaluate Patients With GI Symptoms

Body Surface Gastric Mapping (BSGM) to Evaluate Patients With Gastrointestinal (GI) Symptoms

Sponsor

Children's Hospital of Philadelphia

Enrollment

685 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Functional Gastrointestinal Disorders Gastroparesis Dyspepsia and Other Specified Disorders of Function of Stomach Gastrointestinal Motility Disorders in Children

Summary

The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have their stomach activity recorded for up to 4 hours using the BSGM device and log real-time symptoms. Researchers will compare the recordings of healthy children and children with GI symptoms to define abnormal GI patterns.

Eligibility

Min Age: 8 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Body surface gastric mapping device for people with dyspepsia and other specified disorders of function of stomach, functional gastrointestinal disorders, and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 8 Years to 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBody surface gastric mapping device

A medical device intended to record, store, view and process gastric myoelectrical activity as an aid in the diagnosis of gastrointestinal motility disorders.